Document is current
Any future updates will be listed below
-
Authors
Sumida, Tomokazu S. http://orcid.org/0000-0002-9806-2642
Cheru, Nardos T.
Hafler, David A. http://orcid.org/0000-0003-4664-535X
- License Information
-
More Information
Article History
Accepted: 15 January 2024
First Online: 19 February 2024
Competing interests
: D.A.H. has received research funding from Bristol-Myers Squibb, Novartis, Sanofi and Genentech, and has been a consultant for Bayer Pharmaceuticals, Repertoire, Bristol-Myers Squibb, Compass Therapeutics, EMD Serono, Genentech, Juno therapeutics, Novartis Pharmaceuticals, Proclara Biosciences, Sage Therapeutics and Sanofi Genzyme.
